Short answer
MESA LABORATORIES INC /CO/ (MLAB) filed an 8-K current report with the SEC on March 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Gary Owens out as CEO ~April 13, 2026; separation terms still being determined, no policy disagreement cited.
MESA LABORATORIES INC /CO/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Gary Owens out as CEO ~April 13, 2026; separation terms still being determined, no policy disagreement cited
- Dr. Siddhartha Kadia named incoming President & CEO + Board member, effective ~April 13, 2026; result of formal external search
- Kadia brings 20+ years life sciences/diagnostics exec experience including CEO roles at Calibre Scientific, PhenomeX/Berkeley Lights, and EAG Laboratories
- Base salary $850K with target annual cash bonus ≥100% of base salary (~$850K)
- Equity grant: $3.0M RSUs (ratable 3-year vest) + $3.0M PSUs at target (0–200% payout, 3-year cliff vest); total ~$6.0M initial equity package
Item 7.01 · Regulation FD Disclosure
- Mesa Labs issued a news release on March 9, 2026 with unspecified company updates: full details in Exhibit 99.1
- Reg FD filing ensures material information disclosed simultaneously to all investors; substance of update requires reviewing attached press release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MESA LABORATORIES INC /CO/ 8-K filings
Get the next MLAB 8-K as it lands
Follow MLAB for push alerts, or ask the research agent what this filing means.